In addition, ICA has been demonstrated to attenuate the growth and invasion ability of Human oral squamous cell carcinoma in vitro and in vivo by inducing the down-regulation of Toll-Like Receptor 4 (TLR4)/ NF-κB pathway [20]. Here, NFKB1 is linked to oral cavity squamous cell carcinoma.